To assess health care resource utilization (HRU) and costs associated with comorbid obesity in patients with type 2 diabetes mellitus (T2DM) from a nationally representative US sample. METHODS: The 2009 Medical Expenditure Panel Survey was analyzed to identify adults (≥20 years) with diabetes (ICD-9-CM: 250). T2DM was identified if one of the following criteria was met: 1) evidence of ≥1 oral or non-insulin injectable anti-diabetic medication; 2) diagnosis of diabetes after age 30; 3) diagnosis before age 30 and not on insulin monotherapy. Pregnant women were excluded. Annual HRU and costs were compared for individuals with T2DM based on the presence of comorbid obesity (BMI≥30 kg/m 2 ). A generalized linear regression model adjusting for patient demographic and clinical characteristics was performed to assess the association between comorbid obesity and total health care costs. Population weights were applied to account for the multi-stage sampling design to produce nationally representative estimates. RESULTS: Of the 2,269 T2DM patients (representing 19.2 million individuals in the US), 54.5% were obese. Obese T2DM patients were more likely to be younger (59 vs. 65 years; p<0.01) than non-obese T2DM patients. Obese T2DM patients had similar inpatient hospital (17.8% vs. 17.9%; p=0.99) and emergency room (21.7% vs. 19.5%; p=0.33) utilization but utilized more outpatient hospital visits (33.3% vs. 27.9%; p=0.03), had more prescription medication fills (48.0 vs. 37.1, p<0.01) and higher total health care costs ($12,009 vs. $10,081, p=0.02) than non-obese T2DM patients. After controlling for age, gender, race, income, insured status and comorbidities, obese T2DM patients had total health care costs of 1.19 times those of the non-obese T2DM patients (p=0.04). CONCLUSIONS: Obesity appears to be associated with higher health care costs in T2DM patients. Effective weight management in T2DM patients may be costeffective and should be considered in diabetes treatment plans.
PHS99 TO IDENTIFY COMORBID DEPRESSION IN DIABETES PATIENTS AND COMPARING THE DIFFERENCES IN USE OF HEALTH CARE SERVICES IN DIABETIC PATIENTS WITH AND WITHOUT COMORBID DEPRESSION
Rege S 1 , Quilliam BJ 2 1 University of Rhode Island, Kingston, RI, USA, 2 University of Rhode Island, Kingston, RI, USA OBJECTIVES: To assess the effect of comorbid depression on rates of health care resource utilization in patients with diabetes. METHODS: We carried out a secondary analysis of data from 2008 Medical Expenditure Panel Survey for the year. In contrast to previous research, we identified diabetes and comorbid depression among the adult population by using their self-report. People with diabetes were identified by examining their self report regarding a diabetes diagnosis. We identified patients with diagnosed and undiagnosed depression by using a score of ≥3 on the two-item Patient Health Questionnaire. This unique method of identifying depression has been validated elsewhere. We calculated odds ratios for having depression in respondents with and without diabetes adjusting for demographic factors. We compared the mean unadjusted health care utilization rates in the diabetic people with and without depression. We also assessed the factors that were associated with incidence of comorbid diabetes and the use of health care services. RESULTS: In the year 2008, 2381 respondents suffered from diabetes while 400 respondents suffered from comorbid depression. Diabetics were more likely than non-diabetics to suffer from depression (Adjusted OR 1.20, 95% CI 1.05-1.37). People suffering from this comorbidity were more likely to be females, married, Hispanic and have a lower poor income level. The mean emergency room visits (0.90 vs. 0.41 p<0.001), the mean outpatient visits (19.62 vs. 16.22 p<0.001) and the mean office based visits (215.1 vs. 159.3 p=0.003) were higher in diabetic patients with depression. In the adjusted analyses, depression was associated with an increase in the use of health care resources. CONCLUSIONS: Utilizing a unique way to identify diabetes and depression in the general population, we found that the likelihood of suffering from depression is higher in case of diabetics. Comorbid diabetes and depression is associated with higher use of health services.
PHS100

REDUCING TOTAL HEALTH CARE COSTS BY SHIFTING TO OUTPATIENT (OP) SETTINGS OF CARE FOR THE MANAGEMENT OF GRAM+ ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI)
Khachatryan A 1 , Ektare V 1 , Xue M 1 , Dunne M 2 , Johnson KE 3 , Stephens JM 1 1 Pharmerit International, Bethesda, MD, USA, 2 Durata Therapeutics, Branford, CT, USA, 3 Durata Therapeutics, Chicago, IL, USA OBJECTIVES: Rising health care costs and financial penalties have necessitated treatment strategies for ABSSSI that avoid hospital admissions and reduce length of stay (LOS), hospital acquired infections (HAIs), and readmissions. Providing parenteral antibiotic therapy in OP settings provides an opportunity to shift care outside the hospital to free hospital beds and reduce additional LOS from HAIs. This analysis estimated, from a US payer perspective, cost offsets of treating gram+ ABSSSIs with varied hospital LOS followed by OP care. METHODS: Economic drivers of care were estimated using a literature-based economic model incorporating inpatient (IP) and OP components. The model incorporated equal efficacy, adverse events (AE), resource use, and costs from literature and public sources. Once and twice daily OP infusions to achieve a 14-day treatment were tested to determine cost offsets shifting IP days to OP days. Sensitivity analyses were performed. Costs were adjusted to 2012US$. RESULTS: Total nondrug medical cost for ABSSSI ranged from $8,790-$15,968 for 3 and 7 days IP, respectively, while treatment entirely OP to avoid admission ranged from $3692-$4353. IP medical costs included IP bed-day ($1853) and AE costs ($343). OP care included either daily home care ($194) or infusion center fee ($154), PICC line with fluoroscopy ($786), PICC complications ($188), labs ($102), and physician visit ($222) for evaluation of ABSSSI. IP versus OP cost breakdown was: 3 days IP ($5,902)/11 days OP ($2,888-$3,429); 7 days IP ($13,314)/7 days OP ($2,273-$2,654). Sensitivity analyses revealed OP cost drivers to be IV days, infusion/OP care costs, and PICC costs versus LOS, bed-day cost, and IV days for IP drivers. CONCLUSIONS: Shifting ABSSSI care to OP settings may result in cost savings up to 44%, with potential to prevent HAIs. Typical OP scenarios represent ~33% of total medical cost, with PICC accounting for 28-43% of OP burden. Value of new ABSSSI therapies will be driven by eliminating need for PICC line and ability to reduce/avoid hospital days. Due to the market turbulence facing the hospital industry, the financial viability of teaching hospitals has been severely threatened. Their missions of education, research, and patient care even strengthen this crisis. Therefore, the objective of this study is to conduct a comparative analysis of the cost, volume, and profit (CVP) structure between large nonprofit urban teaching hospitals and small forprofit rural/suburban non-teaching hospitals. The following two hypotheses were developed: 1) large nonprofit urban teaching hospitals tend to have higher fixed cost, lower variable cost, lower total revenue adjusted by case mix index (CMI), and lower return on total assets (ROA), and 2) small for-profit rural/suburban non-teaching hospitals tend to have lower fixed cost, higher variable cost, higher total revenue adjusted by CMI, and higher ROA. Using 117 teaching hospitals and 102 non-teaching hospitals selected from the Medicare Cost Report database in 2005, the results from multiple regression indicated that large nonprofit teaching hospitals located in urban areas are more likely to have higher fixed cost and lower variable cost. While such cost structure doesn't necessarily affect their total revenue adjusted by CMI, it does lead to a lower return on hospitals' total assets. The results support our hypotheses in terms of fixed cost percentage, variable cost percentage, and ROA, but not total revenue adjusted by CMI. The results suggest that cost structure is significantly associated with hospitals' performance. Also, as teaching hospitals' portfolios of services and programs increase (e.g., provision of uncompensated care to Medicare and Medicaid patients and doing research), it becomes strategically necessary and critical to manage the allocation of resources or investments into the fixed capital that supports the business.
PHS101 A COMPARATIVE ANALYSIS OF CVP STRUCTURE OF NONPROFIT TEACHING AND FOR-PROFIT NON-TEACHING HOSPITALS
PHS102 SUPLEMENTARY HEALTH CARE UTILIZATION RESEARCH IN BRAZIL: CHARACTERIZATION OF THE BI.2IM DATABASE
Araújo GTB 1 , Abicalaffe CL 2 , Savian J 2 , Decimoni TC 1 , Santos AM 1 , Fonseca M 3 1 Axia.Bio Consulting, São Paulo, Brazil, 2 2iM S/A, Curitiba, Brazil, 3 Federal University of São Paulo/Axia.Bio Consulting, São Paulo, Brazil OBJECTIVES: The BI.2IM Project started in 2010 to improve costs control and register resource utilization of several Brazilian HMOs based on an already established (2007) administrative database. The project has evolved in 2011 for another utilization related to payment for performance (P4P) and evaluation of standard of resource utilization (in-hospital and medical office based data), allowing to follow identified patients over prolonged periods of time and to study the quantity and cost of health care services provided. Therefore, this 5 million lives database (BI.2iM) probabily allows retrospective health care resource utilization studies based upon the registered data and their related costs. The aim of this study is to verify if BI.2iM database is statistically comparable with the total Brazilian Private Healthcare population in terms of regional distribuition, gender and age. METHODS: The sample quantity of patients was statistically compared with the total private market population in terms of regional distribution and gender. Other available information was accessed and compared too. RESULTS: The sample compares well to the national private market population (sample error of 0,044%) as well as in terms of regional distribution. The BI.2iM database can be searched by ICD10 code, Brazilian codes for procedures and tests and allows follow up of the patient's treatment. CONCLUSIONS: The BI.2iM sample constitutes a well-characterized supplementary health study population statistically comparable to the national private market population. Its results extrapolated to the total supplementary health care together with the public health care database (DATASUS) may enable evaluation the total Brazilian Healthcare market.
PHS103 OUTPATIENT VISITS FOR SCHIZOPHRENIA IN THE UNITED STATES: A NATIONALLY REPRESENTATIVE ANALYSIS USING NAMCS AND NHAMES DATA
Stensland MD, Netzer LM Agile Outcomes Research, Inc., Rochester, MN, USA OBJECTIVES: To characterize the outpatient visits for schizophrenia in the United States in comparison to major depressive disorder (MDD) and general outpatient (GOP) visits. METHODS: The National Ambulatory Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) data from 2003 to 2010 were pooled and weighted to provide national level estimates. Using ICD-9 codes, visits were classified as schizophrenia (295.xx) or MDD (296.2x-296.3x) visits; all others were classified as GOP visits. Estimation methods accounting for the surveys' multistage sampling procedures provided percent- 5%-37 .4%]) visits. CONCLUSIONS: The NAMCS and NHAMCS data provided a representative characterization of outpatient treatment for schizophrenia across different payers in the United States. Outpatient visits for schizophrenia differed from MDD or GOP visits across multiple characteristics, including payer type, physician specialty, and medication use.
PHS104 EFFECT OF INSURANCE COVERAGE ON HEALTH-CARE EXPENDITURES AMONG PATIENTS WITH ARTHRITIS
Almasri DM, Noor AO, Lai L Nova Southeastern University, Ft. Lauderdale, FL, USA OBJECTIVES: To compare the effect of insurance coverage on health-care related expenditures among patients with arthritis in the United States. METHODS: A cross-sectional analysis was conducted. Subjects were derived from the National Medical Expenditures Panel Survey (MEPS) for those whom reported having any type of arthritis in 2009. A series of weighted univariate statistics were applied to examine patient's demographic characteristics (gender, race, age, etc.) and insurance coverage (private, public, and uninsured). We further employed a generalized linear regression model to compare the health-care expenditures (inpatient, emergency room, outpatient, prescription drug) among different insurance status. All analyses utilized SAS PROC SURVEYs' application to adjust for the complex sampling design employed by MEPS database. RESULTS: There were an estimated 55.99 million arthritis patients from 2009 MEPS, in which 8.5 million (15.1%) had rheumatoid arthritis; 21.2 million (37.7%) had osteoarthritis; and 26.5 million (47.2%) had unspecified arthritis. It is estimated that the majority of the arthritis patients 34.9 million (62.35%) were covered by private insurance, 16.5 million (29.5%) were covered by public plans and about 4.5 million (8%) were uninsured. The total medical expenditure for patients with arthritis in 2009 was $522.6 billion. Total prescription expenditures among arthritis patients were $122.1 billion. Per capita medical care expenditures among private, public and uninsured arthritis patients averaged $8,751, $12,093 and $3,730 respectively (P<0.0001). Also, there is a significant difference (P<0.0001) in the prescription expenditures among private, public and uninsured arthritis patients. Average prescription expenditure is $1982.6, $2991.6 and $748 respectively. CONCLUSIONS: Our findings indicate that uninsured arthritis patients had significant lower costs in total health-care expenditure than insured patients. Consistently with other studies, the uninsured have more unmet health needs than insured Americans. Such undertreated and/or underutilized situation may place uninsured people at risk of a serious disability complication.
PHS105 IS OBESITY A SIGNIFICANT PREDICTOR OF ASTHMA, ASTHMA RELATED AND TOTAL HEALTH CARE COSTS AMONG ELDERLY INDIVIDUALS IN THE UNITED STATES?
Shah R, Yang Y University of Mississippi, University, MS, USA OBJECTIVES: To investigate whether obesity is associated with asthma, asthmarelated and total direct medical costs in elderly individuals in the U.S. using pooled 2006-2010 Medical Expenditure Panel Survey (MEPS) data. METHODS: This study is a retrospective analysis of MEPS data from 2006-2010. Individuals 65 years or older were included in the study. Individuals with asthma were identified by ICD-9-CM code 493 or clinical classification code 128. Individuals with a self-reported body mass index greater than 30 kg/m 2 were considered to be obese. A logistic regression model was used to assess the relationship between obesity and asthma. Both asthma-related and total direct medical costs including inpatient, outpatient, prescription medication and office-based physician visit costs were analyzed. All costs were reported in 2010 U.S. dollars,. Generalized linear models with gamma distribution and log link were used to assess the relationship between obesity and direct medical costs. Individual comorbidities and socio-demographic covariates were controlled for in all models. All analyses were conducted using SAS while accounting for the complex survey design of MEPS. RESULTS: Out of 18,305 elderly individuals in MEPS data 2006-2010, 978 were identified as having asthma, of which 595 were obese. Obese elderly individuals were more likely to suffer from asthma as compared to non-obese individuals (odds ratio: 1.649; 95% Confidence Interval:1.306-2.081). Annual asthma-related costs for obese and non-obese asthmatic individuals were $1,585.88 (±94.10) and $1,611.83 (±84.65); annual total (all-cause) costs for obese and non-obese asthmatic individuals were $16,144 (±910.63) and $14,525 (±876.79), respectively. The cost analysis results were not statistically significant. CONCLUSIONS: Elderly obese individuals are at a great risk of suffering from asthma. Although total direct medical cost for obese asthmatic elderly individuals were greater than those of non-obese asthmatics, obesity is not a statistically significant predictor of asthma-related and total direct medical costs among elderly individuals with asthma.
PHS106 GENDER DIFFERENCES IN HEALTH-CARE RELATED EXPENDITURES FOR PATIENTS WITH ARTHRITIS IN THE UNITED STATES
Almasri DM, Lai L Nova Southeastern University, Ft. Lauderdale, FL, USA OBJECTIVES: Our study aimed to examine gender differences in Health-related expenditures for patients with arthritis in the US civilian non-institutionalized population. METHODS: A cross-sectional analysis was conducted using the National Medical Expenditures Panel Survey data (MEPS). Study subjects included patients who reported having any type of arthritis in 2009. The dependent variables include total and out of pocket medical expenditures (in-patients, outpatient, emergency department visits); and total and out of pocket prescription drugs expenditures. A series of weighted t-statistics statistics were used to test the effect of gender on health-related expenditures. To provide national estimates, all analyses incorporated sample weights and standard errors corrections to adjust for the complex sampling design employed by MEPS. RESULTS: There were an estimated 55.988 million arthritis patients from 2009 MEPS, in which 8.5 million (15.1%) had rheumatoid arthritis; 21.2 million (37.7%) had osteoarthritis; and 26.5 million (47.2%) had unspecified arthritis. About 85% of the patients were white and 60.4% were females. Female showed significant higher total medical expenditures than male ($9,633 vs. $8,874) (p<0.0001). Female also showed significant higher out of pocket medical expenditures than male. ($1,337 vs. $1,026) (p<0.0001). The results from prescription total expenditures also showed significant difference (p<0.0001) between male ($2,097) and female ($2,235) arthritis patients. Finally, the results of out of pocket prescription expenditures showed a significant difference (p<0.0001) between male ($414) and female ($500). CONCLUSIONS: The study indicates that women have higher medical care service utilization and higher associated charges than men. The findings provide valuable evidence for future implications of women health care services.
PHS107 USING PHONE TRIAGE WITH RISK STRATIFICATION TO INITIATE LOW BACK PAIN CARE WITHIN A HEALTH CARE SYSTEM
Karlen EK Fairview Health Services, Saint Paul, MN, USA OBJECTIVES: Over 50% of people seeking care for low back pain (LBP) enter through primary care. Primary care physicians (PCPs) often have less training in assessing and treating LBP than physical therapists and medical spine specialists. Nationally, the direct cost to manage LBP has continued to grow and the outcomes have worsened. This pilot initiated LBP care with the highest-value provider type based on the patient's risk level to determine if higher-value care could be delivered. METHODS: For 2 months, patients calling their primary care clinic to schedule an appointment for new LBP were diverted to a nurse line. After passing a red-flag screen, the patients were risk stratified using the Keele STarT Back tool. Low and medium risk patients immediately received reassureance and education in self-management. Those still wanting to see a clinician scheduled with a physical therapist. High risk patients scheduled with medical spine specialists. Patients referred to physical therapy were matched to therapists capable of delivering evidence-based care for their specific risk level. Physical therapists received best-practice guidelines and patient profiles for each of the risk levels. Patient improvement was measured with the Oswestry Disability Index (ODI). RESULTS: Of the 42 LBP patients referred to physical therapy, 90% were matched to physical therapists based on risk level. The cumulative average ODI improvement was 39% in 5.5 visits, a .06 QALY improvement over the previous care model that delivered an average ODI improvement of 27% in 6 visits. Patients receiving care from a medical spine specialist were 56% more likely to have appropriate imaging and 50 times less likely to be prescribed opioids. Estimated direct medical costs savings were 15-31% with 41-61% in total cost savings to the community. CONCLUSIONS: Phone triaging that includes risk stratification delivers higher-value LBP care than traditional care models.
PHS108 A QUALITATIVE EXPLORATION OF PERCEPTIONS TOWARDS PHARMACEUTICAL PRICE WAR AMONG COMMUNITY PHARMACIES IN THE STATE OF PENANG, MALAYSIA
Tan CS, Hassali MA, Saleem F Universiti Sains Malaysia, Penang, Malaysia OBJECTIVES: To evaluate perceptions of community pharmacists towards medicine pricing issues in the model of practice in Malaysia. METHODS: A qualitative approach was adopted. Semi structured interviews were conducted by face to face interview. Purposive sampling technique was used to recruit a convenient sample of full time community pharmacists practising in the State of Penang, Malaysia. All interviews were audio recorded, transcribed verbatim and thematically analysed. RESULTS: A total of 11 community pharmacists were recruited in this study. Thematic content analysis of the interviews identified three main themes: factors causing pharmaceutical price war, potential impact of price war, and recommendations to overcome price war. In general, price war phenomenon has diminished the profit margin of community pharmacists and threatened their survival. Thus the participants were anticipated government could control medicine price. The findings in this study also highlighted participants were dissatisfied with the unethical practise by pharmaceutical company in offering different bonus schemes. The bonus schemes also reported as discriminatory as physician were offered better perks compare to community
